Proteomic technologies for prenatal diagnostics: advances and challenges ahead

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Espert Review of Proteomics

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14789450.6.1.87PMID 19210129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenic factors and preeclampsia.

  2011cited by this paper
• Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood

  2008cited by this paper
• Urine in Clinical Proteomics*

  2008cited by this paper
• Shotgun Proteomic Analysis of Vaginal Fluid From Women in Late Pregnancy

  2008cited by this paper
• Screening for fetal abnormalities with ultrasound

  2008cited by this paper
• iTRAQ experimental design for plasma biomarker discovery.

  2008cited by this paper
• Identification of Proteomic Biomarkers of Preeclampsia in Amniotic Fluid Using SELDI-TOF Mass Spectrometry

  2008cited by this paper
• First-trimester Screening for Chromosomal Abnormalities

  2008cited by this paper
• Proteomic analysis of human follicular fluid using an alternative bottom-up approach.

  2008cited by this paper
• Using Proteomic Analysis of the Human Amniotic Fluid to Identify Histologic Chorioamnionitis

  2008cited by this paper
• Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.

  2008cited by this paper
• Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth

  2008cited by this paper
• Angiogenesis factors and preeclampsia

  2008cited by this paper
• Imaging mass spectrometry reveals unique protein profiles during embryo implantation.

  2008cited by this paper
• Advances in the understanding of eclampsia

  2008cited by this paper
• Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia

  2008cited by this paper
• Rapid prenatal diagnosis using uncultured amniocytes and oligonucleotide array CGH

  2008cited by this paper
• Post-genomics studies and their application to non-invasive prenatal diagnosis.

  2008cited by this paper
• Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21

  2008cited by this paper
• Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses.

  2008cited by this paper
• Placental pathology: a systematic approach with clinical correlations.

  2008cited by this paper
• Inhibins as diagnostic markers in human reproduction.

  2008cited by this paper
• Proteomic analysis of human amniotic fluid from Rh− pregnancy

  2008cited by this paper
• Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid.

  2008cited by this paper
• Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma

  2008cited by this paper
• Association Between Abnormal Uterine Artery Doppler Flow Velocimetry, Risk of Preeclampsia, and Indices of Arterial Structure and Function: A Pilot Study

  2008cited by this paper
• [Proteomics of follicular fluid in mature human follicles and antral follicles: a comparative study with laser desorption/ionization-time of flight-mass spectrometry].

  2008cited by this paper
• Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids

  2008cited by this paper
• Maternal Lipids as Strong Determinants of Fetal Environment and Growth in Pregnancies With Gestational Diabetes Mellitus

  2008cited by this paper
• Comprehensive proteomic analysis of human cervical-vaginal fluid.

  2007cited by this paper
• The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S

  2007cited by this paper
• Proteomics Analysis of Human Amniotic Fluid *S

  2007cited by this paper
• Proteomics: a novel methodology to complement prenatal diagnosis of chromosomal abnormalities and inherited human diseases.

  2007cited by this paper
• Detection of aneuploidy with digital polymerase chain reaction.

  2007cited by this paper
• Proteomic Analysis of Proteins Differentially Expressed in Preeclamptic Trophoblasts

  2007cited by this paper
• Angiogenic factors and preeclampsia.

  2007cited by this paper
• Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.

  2007cited by this paper
• Proteomic analysis of human cervico-vaginal fluid.

  2007cited by this paper
• Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid.

  2007cited by this paper
• Pre‐symptomatic increase in urine‐orosomucoid excretion in pre‐eclamptic women

  2007cited by this paper
• Value of Placental Microbial Evaluation in Diagnosing Intra-amniotic Infection

  2007cited by this paper
• Biochemical markers for the prediction of preterm delivery.

  2007cited by this paper
• Digital PCR for the molecular detection of fetal chromosomal aneuploidy

  2007cited by this paper
• Proteomic analysis and characterisation of human cervico‐vaginal fluid proteins

  2007cited by this paper
• Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia.

  2007cited by this paper
• Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.

  2007cited by this paper
• Molecular aspects of preeclampsia.

  2007cited by this paper
• Comprehensive "proteomic profile" of amniotic fluid may aid prenatal diagnosis.

  2007cited by this paper
• ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy

  2007cited by this paper
• Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection.

  2007cited by this paper
• Aneuploidy screening in the first trimester

  2007cited by this paper
• Proteomic Biomarkers of Intra-amniotic Inflammation: Relationship with Funisitis and Early-onset Sepsis in the Premature Neonate

  2007cited by this paper
• Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes.

  2007cited by this paper
• Specific peptide patterns of follicular fluids at different growth stages analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2007cited by this paper
• Maternal Serum Transformed α-Fetoprotein Levels in Women with Intrauterine Growth Retardation

  2007cited by this paper
• Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing Preeclampsia

  2007cited by this paper
• Proteomic analyses of amniotic fluid: potential applications in health and diseases.

  2007cited by this paper
• Proteome analysis of human amnion and amniotic fluid by two‐dimensional electrophoresis and matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry

  2006cited by this paper
• Proteome analysis of human plasma and amniotic fluid by Off‐Gel™ isoelectric focusing followed by nano‐LC‐MS/MS

  2006cited by this paper
• Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes.

  2006cited by this paper
• Innovations: Functional and quantitative proteomics using SILAC

  2006cited by this paper
• Proteomic analysis of amniotic fluid in pregnancies with Down syndrome

  2006cited by this paper
• Proteomic Analysis on the Alteration of Protein Expression in the Placental Villous Tissue of Early Pregnancy Loss

  2006cited by this paper
• Proteomic analysis of recurrent spontaneous abortion: Identification of an inadequately expressed set of proteins in human follicular fluid

  2006cited by this paper
• Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9–12 weeks' gestation

  2006cited by this paper
• Use of routinely collected amniotic fluid for whole-genome expression analysis of polygenic disorders.

  2006cited by this paper
• Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells

  2006cited by this paper
• Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.

  2006cited by this paper
• The normal human amniotic fluid supernatant proteome.

  2006cited by this paper
• Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

  2006cited by this paper
• Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

  2006cited by this paper
• Proteome analysis of human follicular fluid.

  2006cited by this paper
• A Simple Parallel Analytical Method of Prenatal Screening

  2006cited by this paper
• Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis

  2006cited by this paper
• First-trimester screening for chromosomal abnormalities.

  2005cited by this paper
• The Effect of Maternal Asthma on Placental and Cord Blood Protein Profiles

  2005cited by this paper
• The amniotic fluid cell proteome

  2005cited by this paper
• Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant

  2005cited by this paper
• Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammation

  2005cited by this paper
• Amniotic Fluid: Not Just Fetal Urine Anymore

  2005cited by this paper
• The role of proteomics in the assessment of premature rupture of fetal membranes.

  2005cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Evidence for the regulation of alternative splicing via complementary DNA sequence repeats

  2005cited by this paper
• Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.

  2005cited by this paper
• Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid.

  2005cited by this paper
• Second‐trimester levels of pregnancy‐associated plasma protein‐A and free β‐hCG in pregnancies with trisomy 13

  2005cited by this paper
• Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry.

  2005cited by this paper
• Peptide patterns of laser dissected human trophoblasts analyzed by matrix‐assisted laser desorption/ionisation‐time of flight mass spectrometry

  2005cited by this paper
• Second trimester serum markers.

  2005cited by this paper
• The use of proteomics for the assessment of clinical samples in research.

  2004cited by this paper
• Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.

  2004cited by this paper
• Use of proteomic patterns as a novel screening tool in pre-eclampsia

  2004cited by this paper
• Post-genome molecular diagnostics in obstetrics

  2004cited by this paper
• The Human Plasma Proteome

  2004cited by this paper
• Proteomic technology and its biomedical applications.

  2003cited by this paper
• Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach

  2003cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics*

  2002cited by this paper

• Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis

  2022cites this paper
• Identification of Gravida Serum Biomarkers for Noninvasive Prenatal Diagnosis Fetal Congenital Heart Disease

  2022cites this paper
• Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia.

  2021cites this paper
• MULTIOMIC patterns in body fluids: Technological challenge with a great potential to implement the advanced paradigm of 3P medicine.

  2019cites this paper
• Advances in the proteomics of amniotic fluid to detect biomarkers for chromosomal abnormalities and fetomaternal complications during pregnancy

  2019cites this paper
• Fetal neurology: Principles and practice with a life-course perspective.

  2019cites this paper
• Prenatal maternal biomarkers for the early diagnosis of congenital malformations: A review

  2019cites this paper
• Potential role of "omics" technique in prenatal diagnosis of congenital heart defects.

  2018cites this paper
• Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects

  2016cites this paper
• Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?

  2015influential citation
• Establishment of a decision tree model for diagnosis of early rheumatoid arthritis by proteomic fingerprinting

  2015cites this paper
• Amniotic Fluid

  2014cites this paper
• A Fractal Analysis of the Detection of Biomarkers for Different Diseases on Biosensor Surfaces

  2014cites this paper
• Prenatal Diagnosis, Where and How: No Way Out?

  2014cites this paper
• Detection of Cancer Biomarkers on Biosensor Surfaces

  2014cites this paper
• Maternal plasma biomarkers for down syndrome: present and future.

  2013cites this paper
• Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker.

  2013cites this paper
• Peripartum consultations expand the role of the fetal/neonatal neurologist.

  2012cites this paper
• Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum

  2012cites this paper
• Non Invasive Prenatal Diagnosis of Aneuploidy: Next Generation Sequencing or Fetal DNA Enrichment?

  2012cites this paper
• Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA

  2012cites this paper
• An Interdisciplinary Fetal/Neonatal Neurology Program

  2012cites this paper
• Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach*

  2012cites this paper
• Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads

  2012cites this paper
• Grundlagen diagnostischer Tests und Screeningverfahren

  2011cites this paper
• Urinproteomanalytik

  2011cites this paper
• Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met?

  2011cites this paper
• Application of proteomics for prenatal diagnosis of Down syndrome: Systematic review and a meta-analysis

  2011cites this paper
• Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation.

  2011cites this paper
• Proteomic analysis of amniotic fluid for the diagnosis of fetal aneuploidies

  2011cites this paper
• Potential applications of human saliva as diagnostic fluid

  2011cites this paper
• Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery

  2010cites this paper
• Innovation of prenatal genetic diagnostics: in relation to improvement of care

  2010cites this paper
• Proteomics of bacterial pathogenicity: Therapeutic implications

  2010cites this paper
• MEDICINA MATERNO-INFANTILE, PEDIATRIA DELLO SVILUPPO E DELL'EDUCAZIONE, PERINATOLOGIA RICERCA DI BIOMARKERS CERVICO-VAGINALI NELLE GRAVIDANZE AD ALTO RISCHIO: IL RUOLO DELLA PROTEOMICA

  2010cites this paper
• Classification of Genes and Putative Biomarker Identification Using Distribution Metrics on Expression Profiles

  2010cites this paper
• Surface plasmon resonance biosensor for parallelized detection of protein biomarkers in diluted blood plasma.

  2010cites this paper
• High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease

  2010cites this paper
• Prenatal diagnosis of fetal aneuploidies: post-genomic developments

  2010cites this paper
• Cancer proteomics : Method development for mass spectrometry based analysis of clinical materials

  2009cites this paper
• Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake

  year unknowncites this paper